Pulmonary complication, postoperative SARS-CoV-2 infection rates lower with COVID-19-free pathways
Second COVID-19 Vaccine Trial Paused for Unexplained Illness
Johnson & Johnson stopped its COVID-19 vaccine trial, which began phase 3 testing last month